The Association of the British Pharmaceutical Industry has agreed the terms of the 2019 Pharmaceutical Price Regulation Scheme (PPRS) with the government, which is expected to come into effect from January.
Read More
The UK’s Competition and Markets Authority has provisionally ruled that Concordia abused its dominant position to overcharge the NHS by millions of pounds for an essential thyroid drug.
Read More
The UK pharmaceutical industry has paid the Department of Health £190 million during the first two quarters of 2017 under the 2014 Pharmaceutical Price Regulation Scheme (PPRS).
Read More
The UK pharmaceutical industry has now contributed £1.3 billion to underwrite growth in the NHS medicines bill, but overall spend remains flat.
Read More
The National Health Service’s annual drugs bill is being inflated by some £262 million through “extortionate” price hikes on a group of medicines controlled by a handful of millionaire businessmen, claims a report in The Times.
Read More
